The Path to a Better Tuberculosis Vaccine Runs Through Montana

Montana researchers are at the forefront of developing a more potent tuberculosis (TB) vaccine, aiming to combat a disease that has claimed more lives than any other infectious ailment. The current BCG vaccine, introduced in 1921, shows limited effectiveness in adolescents and adults, spurring a global quest for a more robust solution.

Precision vaccination tailors immunity to individuals, potentially offering lifelong protection with a single dose, a goal pursued for TB and other diseases like influenza and COVID-19. Despite groundbreaking research, Montana's anti-vaccination stance poses challenges. However, with ongoing clinical trials and collaborations, hopes are high for a breakthrough in TB prevention within the next five years. Read more from KFF here.